Wendy L. Yarno - Dec 2, 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein
Stock symbol
TARS
Transactions as of
Dec 2, 2022
Transactions value $
$0
Form type
4
Date filed
12/6/2022, 04:59 PM
Previous filing
Oct 6, 2022
Next filing
Apr 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARS Restricted Stock Units Award $0 +5K $0.00 5K Dec 2, 2022 Common Stock 5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F2 RSUs granted in connection with the Reporting Person's service as the Lead Independent Director. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.